Compare Abeona Therapeutics Inc (ABEO) vs Oxford Lane Capital Corp (OXLC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Oxford Lane Capital Corp — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Oxford Lane Capital Corp trades at $9.3 (market cap $909.61M). The key difference: Oxford Lane Capital Corp is far larger — about 2.2× Abeona Therapeutics Inc's market cap, and Oxford Lane Capital Corp pays a 25.76% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | OXLC | |
|---|---|---|
Market Cap | $421.19M | $909.61M |
Sector | Health | Financials |
52-Week High | $7.45 | $18.75 |
52-Week Low | $4.17 | $8.15 |
Enterprise Value | $276.10M | — |
Dividend Yield | — | 25.76% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Oxford Lane Capital Corp
Oxford Lane Capital Corp. is a non-diversified, closed-end management investment company. Its primary investment objective is to achieve high current income, with a secondary objective of capital appreciation. The company primarily invests in equity and junior debt tranches of collateralized loan obligations (CLOs), which are pools of corporate loans. OXLC is known for its high-yield distribution policy and provides investors with leveraged exposure to the CLO market.
Read more on OXLC →
